Surgical outcomes in patients with multiple sclerosis (MS) following metabolic surgery appear to be similar compared to those of the general bariatric population.
Objective:
To study the impact of metabolic surgery on the clinical course of MS.
Methods:
Using data from the Scandinavian Obesity Surgery Registry and the Swedish Multiple Sclerosis register, we compared disease outcomes in 122 cases of MS who had undergone metabolic surgery with those of 122 cases of MS without surgery, matched by a two-staged Propensity score match, including age at disease onset, sex, MS phenotype, body mass index, and preoperative severity of MS as measured by the Expanded Disability Status Scale.
Results:
The time to 6-month confirmed disability progression during the first five years postbaseline was shorter among the surgical patients (hazard ratio (HR) = 2.31, 95% confidence interval (CI) = 1.09–4.90; p = 0.03). No differences were observed regarding postoperative annual relapse rate (p = 0.24) or time to first postoperative relapse (p = 0.52).
Conclusion:
Although metabolic surgery appears to be a safe and efficient treatment of obesity in patients with MS, the clinical course of the disease might be negatively affected. Long-term nutritional follow-up after surgery and supplementation maintenance are crucial, particularly among those with preoperative deficits.
Abarca-GomezLAbdeenZAHamidZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet2017; 390: 2627–2642.
2.
Stampanoni BassiMIezziEButtariF, et al. Obesity worsens central inflammation and disability in multiple sclerosis. Mult Scler2020; 26(10): 1237–1246.
3.
CastroKNtranosAAmatrudaM, et al. body mass index in multiple sclerosis modulates ceramide-induced DNA methylation and disease course. Ebiomedicine2019; 43: 392–410.
4.
StenbergESzaboEAgrenG, et al. Early complications after laparoscopic gastric bypass surgery: Results from the Scandinavian Obesity Surgery Registry. Ann Surg2014; 260(6): 1040–1047.
5.
le RouxCWHeneghanHM. Bariatric surgery for obesity. Med Clin North Am2018; 102: 165–182.
6.
SjöströmLPeltonenMJacobsonP, et al. Bariatric surgery and long-term cardiovascular events. JAMA2012; 307: 56–65.
7.
SundbomMHedbergJMarskR, et al. Substantial decrease in comorbidity 5 years after gastric bypass: A population-based study from the Scandinavian Obesity Surgery Registry. Ann Surg2017; 265(6): 1166–1171.
8.
AskarpourMKhaniDSheikhiA, et al. Effect of bariatric surgery on serum inflammatory factors of obese patients: A systematic review and meta-analysis. Obes Surg2019; 29(8): 2631–2647.
9.
StenbergEForsbergLHedströmA, et al. Bariatric and metabolic surgery in patients with morbid obesity and multiple sclerosis—A nationwide, matched cohort study. Surg Obes Relat Dis2021; 17(6): 1108–1114.
10.
BencsathKJammoulAAminianA, et al. Outcomes of bariatric surgery in morbidly obese patients with multiple sclerosis. J Obes2017; 2017: 1935204.
11.
SundbomMNäslundINäslundE, et al. High acquisition rate and internal validity in the Scandinavian Obesity Surgery Registry. Surg Obes Relat Dis2021; 17: 606–614.
12.
HillertJStawiarzL. The Swedish MS registry—Clinical support tool and scientific resource. Acta Neurol Scand2015; 132(199): 11–19.
13.
HobartJLampingDFitzpatrickR, et al. The multiple sclerosis impact scale (MSIS-29): A new patient-based outcome measure. Brain2001; 124(Pt5): 962–973.
14.
CignarellaFCantoniCGhezzziL, et al. Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota. Cell Metab2018; 27: 1222–1235.
15.
NäslundEStenbergEHofmannR, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with previous myocardial infarction and severe obesity: A nationwide cohort study. Circulation2021; 143: 1458–1467.
16.
WeisbergSPMcCannDDesaiM, et al. Obesity is associated with accumulation of macrophages in adipose tissue. J Clin Invest2003; 112: 1821–1830.
17.
AlshamraniFTurkistaniLAlAmriN, et al. Multiple sclerosis following bariatric surgery: A report of five cases. AMJ2019; 12: 337–343.
18.
BitafaranSAmaniFSahraianMA, et al. The first attack of multiple sclerosis presented immediately after voluntary and intensive weight loss. A case series. Iran J Neurol2017; 16: 41–42.
19.
MatareseGCarrieriPBMontellaS, et al. Leptin as a metabolic link to multiple sclerosis. Nat Rev Neurol2010; 6(8): 455–461.
20.
Damms-MachadoAFriedrichAKramerKM, et al. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes Surg2012; 22(6): 881–889.
21.
Ben-PoratTElazaryRGoldenshlugerA, et al. Nutritional deficiencies four years after laparoscopic sleeve gastrectomy—Are supplements required for a lifetime?Surg Obes Relat Dis2017; 13: 1138–1144.
22.
Calderón-OspinaCANava-MesaMO. B vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther2020; 26: 5–13.
23.
BaltruschS. The role of neurotropic B vitamins in nerve regeneration. Biomed Res Int2021; 2021: 9968228.
24.
PunchaiSHanipahZNMeisterKM, et al. Neurologic manifestations of vitamin B deficiency after bariatric surgery. Obes Surg2017; 27(8): 2079–2082.
25.
JalilvandABlaszczakANeedlemanB, et al. Vitamin A deficiency in patients undergoing sleeve gastrectomy and gastric bypass: A 2-year, single-center review. J Laparoendosc Adv Surg Tech A2020; 30(1): 20–30.
26.
MungerKLLevinLIHollisBW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA2006; 296: 2832–2838.
27.
SalzerJHallmansGNyströmM. Vitamin A and systemic inflammation as protective factors in multiple sclerosis. Mult. Scler2013; 19: 1046–1051.
28.
Loken-AmsrudKIMyhrKMBakkeSJ, et al. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler2013; 19(4): 451–457.
29.
PiedelFRockaAPiwekM, et al. Correlation between vitamin D and alterations in MRI among patients with multiple sclerosis. Ann Agric Environ Med2021; 28: 372–377.
30.
LutholdRVFernandesGRFranco-de-MoraesAC, et al. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism2017; 69: 76–86.
31.
RiccioPRossanoR. Diet, gut microbiota, and vitamins D + A in multiple sclerosis. Neurotherapeutics2018; 15(1): 75–91.
32.
AndradeLChioteISantos-CruzA, et al. Protein intake, adherence to vitamin–mineral supplementation, and dumping syndrome in patients undergoing one anastomosis gastric bypass. Obes Surg2021; 31(8): 3557–3564.
33.
NajahHDuffillotCGronnierC, et al. Guidelines compliance in bariatric surgery: A French nationwide study. Surg Obes Relat Dis2021; 18(5): 620–627.
34.
GBD. 2016 Multiple Sclerosis Collaborators. Global, regional, and national burden of multiple sclerosis 1990–2016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol2019; 18: 269–285.
